EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in mice

Rui Xing, Shanshan Wang, Yixin Wang, Geng Chen, Rui Zhou, Xuelian Wang, Li Ma, Yongjun Yang, Sheng Li, Ming Zhao, Yinwei Zhang, Yuanyuan Fu und 5 weitere

Cancer Immunology, Immunotherapy · 2026

DOI: 10.1007/s00262-026-04411-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Rui Xing und 16 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Junjian Biotechnology Co., Ltd., Ningbo, 315832, China. Hauptthemen laut MEDLINE: Oncogene Proteins, Viral, Papillomavirus E7 Proteins, Repressor Proteins, Papillomavirus Vaccines. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncogene Proteins, ViralPapillomavirus E7 ProteinsRepressor ProteinsPapillomavirus VaccinesCancer VaccinesPapillomavirus InfectionsmRNA VaccinesT-LymphocytesUterine Cervical NeoplasmsAnimalsFemaleMiceMice, Inbred C57BLHumansHuman papillomavirus 16CD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

Antitumor immunityCancer immunotherapyHPV16 E6/E7 antigensImmunogenicityLNPsaRNA

Substanzen

Oncogene Proteins, ViralPapillomavirus E7 ProteinsE6 protein, Human papillomavirus type 16oncogene protein E7, Human papillomavirus type 16Repressor ProteinsPapillomavirus VaccinesCancer VaccinesmRNA Vaccines

Autor:innen und Institutionen

  • Ningbo Junjian Biotechnology Co., Ltd., Ningbo, 315832, China.
  • Affiliated Women and Children's Hospital, Ningbo University, Ningbo, 315012, China.
  • Department of Medical Services, The First Affiliated Hospital of Ningbo University, Ningbo, 315000, China.
  • Department of Geriatrics, The First Affiliated Hospital of Ningbo University, Ningbo, 315000, China.
  • Ningbo Institute of Oceanography, Ningbo, 315211, China.
  • Engineering Research Center of Novel Vaccine of Zhejiang Province, Hangzhou Medical College, Hangzhou, 310059, China.

Zitieren

APA

Xing, R., Wang, S., Wang, Y., Chen, G., Zhou, R., Wang, X., Ma, L., Yang, Y., Li, S., Zhao, M., Zhang, Y., Fu, Y., Cui, F., Meng, G., Zheng, B., Xiong, C., & Wang, Y. (2026). A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in mice. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04411-1

Vancouver

Xing R, Wang S, Wang Y, Chen G, Zhou R, Wang X, et al. A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in mice. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04411-1

BibTeX
@article{Xing2026,
  author = {Xing, Rui and Wang, Shanshan and Wang, Yixin and Chen, Geng and Zhou, Rui and Wang, Xuelian and Ma, Li and Yang, Yongjun and Li, Sheng and Zhao, Ming and Zhang, Yinwei and Fu, Yuanyuan and Cui, Fujie and Meng, Gao and Zheng, Bin and Xiong, Changyun and Wang, Youru},
  title = {A low-dose self-amplifying mRNA vaccine encoding HPV16 E6/E7 induces potent T-cell immunity and antitumor protection in mice},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-026-04411-1}
}
Kostenlos starten →